Sildenafil Administration to Treat Neonatal Encephalopathy

Clinical trial NCT02812433 · COMPLETED

Trial details

NCT number: NCT02812433
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neonatal Encephalopathy

Start date: 2016-07-01
Primary completion: 2019-01-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.